Skip to main content
Erschienen in: Urolithiasis 1/2015

01.01.2015 | Invited Review

On the origin of calcium oxalate monohydrate papillary renal stones

verfasst von: Fèlix Grases, Antonia Costa-Bauzá, Carlo R. Bonarriba, Enrique C. Pieras, Rafael A. Fernández, Adrián Rodríguez

Erschienen in: Urolithiasis | Sonderheft 1/2015

Einloggen, um Zugang zu erhalten

Abstract

Calcium oxalate monohydrate (COM) papillary calculi can be initiated by subepithelial calcification of the renal papillae. Hydroxyapatite disruption of the papillary epithelial layer can become the nidus of a COM papillary calculus. This study evaluated the causes of papillary tissue calcifications in 60 patients with calcium oxalate lithiasis, 30 with COM papillary and 30 with calcium oxalate dihydrate (COD) calculi. Urinary redox potential was higher in the COM than the COD group, suggesting that the former is more deficient in antioxidants due to increased oxidative stress. Urinary calcium was significantly higher in the COD group, whereas urinary oxalate was significantly higher in the COM group, suggesting a greater degree of oxidative injury of renal cells. Evaluations of their diets showed that both groups consumed low amounts of phytate-rich products. Of chronic diseases possibly associated with urolithiasis, only the prevalence of gastroduodenal ulcer differed significantly, being higher in the COM group and suggesting that epithelial lesions are common to gastroduodenal ulcers and COM papillary renal stones. Occupational exposure to cytotoxic products occurred in 47 % of the COM and 27 % of the COD group, but this difference was not statistically significant. These findings indicate that oxidative stress is associated with injury to papillary tissue and that this is the origin of intrapapillary calcifications. The continuation of this process is due to modulators and/or deficiencies in inhibitors of crystallization. Identifying and eliminating the causes of injury may prevent recurrent episodes in patients with papillary COM calculi.
Literatur
1.
Zurück zum Zitat Daudon M, Bader CA, Jungers P (1993) Urinary calculi: review of classification methods and correlations with etiology. Scanning Microsc 7:1081–1106PubMed Daudon M, Bader CA, Jungers P (1993) Urinary calculi: review of classification methods and correlations with etiology. Scanning Microsc 7:1081–1106PubMed
2.
Zurück zum Zitat Grases F, Costa-Bauzá A, Ramis M, Montesinos V, Conte A (2002) Simple classification of renal calculi closely related to their micromorphology and etiology. Clin Chim Acta 322:29–36PubMedCrossRef Grases F, Costa-Bauzá A, Ramis M, Montesinos V, Conte A (2002) Simple classification of renal calculi closely related to their micromorphology and etiology. Clin Chim Acta 322:29–36PubMedCrossRef
3.
Zurück zum Zitat Conti C, Brambilla L, Colombo C, Dellasega D, Diego Gatta C, Realini M, Zerbi G (2010) Stability and transformation mechanism of weddellite nanocrystals studied by X-ray diffraction and infrared spectroscopy. Phys Chem Chem Phys 12:14560–14566PubMedCrossRef Conti C, Brambilla L, Colombo C, Dellasega D, Diego Gatta C, Realini M, Zerbi G (2010) Stability and transformation mechanism of weddellite nanocrystals studied by X-ray diffraction and infrared spectroscopy. Phys Chem Chem Phys 12:14560–14566PubMedCrossRef
5.
Zurück zum Zitat Prien EL (1975) The riddle of Randall’s plaques. J Urol 114:500–507PubMed Prien EL (1975) The riddle of Randall’s plaques. J Urol 114:500–507PubMed
6.
Zurück zum Zitat Evan AP, Lingeman JE, Coe FL, Parks JH, Bledsoe SB, Shao Y, Sommer AJ, Paterson RF, Kuo RL, Grynpas M (2003) Randall’s plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest 111:607–616PubMedCentralPubMedCrossRef Evan AP, Lingeman JE, Coe FL, Parks JH, Bledsoe SB, Shao Y, Sommer AJ, Paterson RF, Kuo RL, Grynpas M (2003) Randall’s plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest 111:607–616PubMedCentralPubMedCrossRef
7.
Zurück zum Zitat Kim SC, Coe FL, Tinmouth WW, Kuo RL, Paterson RF, Parks JH, Munch LC, Evan AP, Lingeman JE (2005) Stone formation is proportional to papillary surface coverage by Randall’s plaque. J Urol 173:117–119PubMedCrossRef Kim SC, Coe FL, Tinmouth WW, Kuo RL, Paterson RF, Parks JH, Munch LC, Evan AP, Lingeman JE (2005) Stone formation is proportional to papillary surface coverage by Randall’s plaque. J Urol 173:117–119PubMedCrossRef
8.
Zurück zum Zitat O’Connor RC, Worcester EM, Evan AP, Meehan S, Kuznetsov D, Laven B, Sommer AJ, Bledsoe SB, Parks JH, Coe FL, Grynpas M, Gerber GS (2005) Nephrolithiasis and nephrocalcinosis in rats with small bowel resection. Urol Res 33:105–115PubMedCrossRef O’Connor RC, Worcester EM, Evan AP, Meehan S, Kuznetsov D, Laven B, Sommer AJ, Bledsoe SB, Parks JH, Coe FL, Grynpas M, Gerber GS (2005) Nephrolithiasis and nephrocalcinosis in rats with small bowel resection. Urol Res 33:105–115PubMedCrossRef
9.
Zurück zum Zitat Evan AP, Coe FL, Rittling SR, Bledsoe SM, Shao Y, Lingeman JE, Worcester EM (2005) Apatite plaque particles in inner medulla of kidneys of calcium oxalate stone formers: osteopontin localization. Kidney Int 68:145–154PubMedCrossRef Evan AP, Coe FL, Rittling SR, Bledsoe SM, Shao Y, Lingeman JE, Worcester EM (2005) Apatite plaque particles in inner medulla of kidneys of calcium oxalate stone formers: osteopontin localization. Kidney Int 68:145–154PubMedCrossRef
10.
Zurück zum Zitat Grases F, García-Ferragut L, Costa- Bauzá A (1998) Analytical study of renal calculi. A new insight. Recent Res Dev Pure Appl Anal Chem 1:187–206 Grases F, García-Ferragut L, Costa- Bauzá A (1998) Analytical study of renal calculi. A new insight. Recent Res Dev Pure Appl Anal Chem 1:187–206
11.
Zurück zum Zitat Costa-Bauza A, Grases F, Fakier S, Rodriguez A (2013) A novel metal-dye system for urinary phytate detection at micro-molar levels in rats. Anal Methods 5:3016–3022CrossRef Costa-Bauza A, Grases F, Fakier S, Rodriguez A (2013) A novel metal-dye system for urinary phytate detection at micro-molar levels in rats. Anal Methods 5:3016–3022CrossRef
12.
Zurück zum Zitat Conte A, Genestar C, Grases F (1990) Relation between calcium oxalate hydrate form found in renal calculi and some urinary parameters. Urol Int 45:25–27PubMedCrossRef Conte A, Genestar C, Grases F (1990) Relation between calcium oxalate hydrate form found in renal calculi and some urinary parameters. Urol Int 45:25–27PubMedCrossRef
13.
Zurück zum Zitat Pierratos AE, Khalaff H, Cheng PT, Psihramis K, Jewett MA (1994) Clinical and biochemical differences in patients with pure calcium oxalate monohydrate and calcium oxalate dihydrate kidney stones. J Urol 151:571–574PubMed Pierratos AE, Khalaff H, Cheng PT, Psihramis K, Jewett MA (1994) Clinical and biochemical differences in patients with pure calcium oxalate monohydrate and calcium oxalate dihydrate kidney stones. J Urol 151:571–574PubMed
14.
Zurück zum Zitat Tsujihata M, Tsujikawa K, Tei N, Yoshimura K, Okuyama A (2006) Urinary macromolecules and renal tubular cell protection from oxalate injury: comparison of normal subjects and recurrent stone formers. Int J Urol 13:197–201PubMedCrossRef Tsujihata M, Tsujikawa K, Tei N, Yoshimura K, Okuyama A (2006) Urinary macromolecules and renal tubular cell protection from oxalate injury: comparison of normal subjects and recurrent stone formers. Int J Urol 13:197–201PubMedCrossRef
15.
Zurück zum Zitat Davalos M, Konno S, Eshghi M, Choudhury M (2010) Oxidative renal cell injury induced by calcium oxalate crystal and renoprotection with antioxidants: a possible role of oxidative stress in nephrolithiasis. J Endourol 24:339–345PubMedCrossRef Davalos M, Konno S, Eshghi M, Choudhury M (2010) Oxidative renal cell injury induced by calcium oxalate crystal and renoprotection with antioxidants: a possible role of oxidative stress in nephrolithiasis. J Endourol 24:339–345PubMedCrossRef
16.
Zurück zum Zitat Grases F, March JG, Prieto RM, Simonet BM, Costa-Bauzá A, García-Raja A, Conte A (2000) Urinary phytate in calcium oxalate stone formers and healthy people—dietary effects on phytate excretion. Scand J Urol Nephrol 34:162–164PubMedCrossRef Grases F, March JG, Prieto RM, Simonet BM, Costa-Bauzá A, García-Raja A, Conte A (2000) Urinary phytate in calcium oxalate stone formers and healthy people—dietary effects on phytate excretion. Scand J Urol Nephrol 34:162–164PubMedCrossRef
17.
Zurück zum Zitat Prieto RM, Fiol M, Perello J, Estruch R, Ros E, Sanchis P, Grases F (2010) Effects of Mediterranean diets with low and high proportions of phytate-rich foods on the urinary phytate excretion. Eur J Nutr 49:321–326PubMedCrossRef Prieto RM, Fiol M, Perello J, Estruch R, Ros E, Sanchis P, Grases F (2010) Effects of Mediterranean diets with low and high proportions of phytate-rich foods on the urinary phytate excretion. Eur J Nutr 49:321–326PubMedCrossRef
18.
Zurück zum Zitat McCord JM (1993) Human disease, free radicals and the oxidant/antioxidant balance. J Free Radic Res 26:351–357 McCord JM (1993) Human disease, free radicals and the oxidant/antioxidant balance. J Free Radic Res 26:351–357
19.
Zurück zum Zitat Benzie IF, Strain JJ (1996) The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Anal Biochem 239:70–76PubMedCrossRef Benzie IF, Strain JJ (1996) The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Anal Biochem 239:70–76PubMedCrossRef
20.
Zurück zum Zitat Hayes WA, Mills DS, Neville RF, Kiddie J, Collins LM (2011) Determination of the molar extinction coefficient for the ferric reducing/antioxidant power assay. Anal Biochem 416:202–205PubMedCrossRef Hayes WA, Mills DS, Neville RF, Kiddie J, Collins LM (2011) Determination of the molar extinction coefficient for the ferric reducing/antioxidant power assay. Anal Biochem 416:202–205PubMedCrossRef
21.
22.
Zurück zum Zitat Khan SR (2013) Reactive oxygen species as the molecular modulators of calcium oxalate kidney stone formation: evidence from clinical and experimental investigations. J Urol 189:803–811PubMedCrossRef Khan SR (2013) Reactive oxygen species as the molecular modulators of calcium oxalate kidney stone formation: evidence from clinical and experimental investigations. J Urol 189:803–811PubMedCrossRef
23.
Zurück zum Zitat Ouyang JM, Yao XQ, Tan J, Wang FX (2011) Renal epithelial cell injury and its promoting role in formation of calcium oxalate monohydrate. J Biol Inorg Chem 16:405–416PubMedCrossRef Ouyang JM, Yao XQ, Tan J, Wang FX (2011) Renal epithelial cell injury and its promoting role in formation of calcium oxalate monohydrate. J Biol Inorg Chem 16:405–416PubMedCrossRef
24.
Zurück zum Zitat Bazin D, Daudon M, Combes C, Rey C (2012) Characterization and some physicochemical aspects of pathological microcalcifications. Chem Rev 112:5092–5120PubMedCrossRef Bazin D, Daudon M, Combes C, Rey C (2012) Characterization and some physicochemical aspects of pathological microcalcifications. Chem Rev 112:5092–5120PubMedCrossRef
25.
Zurück zum Zitat Grases F, Prieto RM, Gomila I, Sanchis P, Costa-Bauzá A (2009) Phytotherapy and renal stones: the role of antioxidants. A pilot study in Wistar rats. Urol Res 37:35–40PubMedCrossRef Grases F, Prieto RM, Gomila I, Sanchis P, Costa-Bauzá A (2009) Phytotherapy and renal stones: the role of antioxidants. A pilot study in Wistar rats. Urol Res 37:35–40PubMedCrossRef
26.
Zurück zum Zitat Khan A, Khan SR, Gilani AH (2012) Studies on the in vitro and in vivo antiurolithic activity of Holarrhena antidysenterica. Urol Res 40:671–681PubMedCentralPubMedCrossRef Khan A, Khan SR, Gilani AH (2012) Studies on the in vitro and in vivo antiurolithic activity of Holarrhena antidysenterica. Urol Res 40:671–681PubMedCentralPubMedCrossRef
27.
Zurück zum Zitat Chennasamudram SP, Kudugunti S, Boreddy PR, Moridani MY, Vasylyeva TL (2012) Renoprotective effects of (+)-catechin in streptozotocin-induced diabetic rat model. Nutr Res 32:347–356PubMedCrossRef Chennasamudram SP, Kudugunti S, Boreddy PR, Moridani MY, Vasylyeva TL (2012) Renoprotective effects of (+)-catechin in streptozotocin-induced diabetic rat model. Nutr Res 32:347–356PubMedCrossRef
28.
Zurück zum Zitat Gandhi M, Aggarwal M, Puri S, Singla SK (2013) Prophylactic effect of coconut water (Cocos nucifera L.) on ethylene glycol induced nephrocalcinosis in male wistar rat. Int Braz J Urol 39:108–117PubMedCrossRef Gandhi M, Aggarwal M, Puri S, Singla SK (2013) Prophylactic effect of coconut water (Cocos nucifera L.) on ethylene glycol induced nephrocalcinosis in male wistar rat. Int Braz J Urol 39:108–117PubMedCrossRef
29.
Zurück zum Zitat Anderson HC, Morris DC (1993) Mineralization. In: Mundy GR, Martin TJ (eds) Physiology and pharmacology of bone. Springer, New York, pp 267–298CrossRef Anderson HC, Morris DC (1993) Mineralization. In: Mundy GR, Martin TJ (eds) Physiology and pharmacology of bone. Springer, New York, pp 267–298CrossRef
30.
Zurück zum Zitat Steitz SA, Speer MY, McKee MD, Liaw L, Almeida M, Yang H, Giachelli CM (2002) Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification. Am J Pathol 161:2035–2046PubMedCentralPubMedCrossRef Steitz SA, Speer MY, McKee MD, Liaw L, Almeida M, Yang H, Giachelli CM (2002) Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification. Am J Pathol 161:2035–2046PubMedCentralPubMedCrossRef
31.
Zurück zum Zitat Romberg RW, Werness PG, Riggs BL, Mann KG (1986) Inhibition of hydroxyapatite crystal growth by bonespecific and other calcium-binding proteins. Biochemistry 25:1176–1180PubMedCrossRef Romberg RW, Werness PG, Riggs BL, Mann KG (1986) Inhibition of hydroxyapatite crystal growth by bonespecific and other calcium-binding proteins. Biochemistry 25:1176–1180PubMedCrossRef
32.
Zurück zum Zitat Boskey AL, Maresca M, Ullrich W, Doty SD, Butler WT, Prince CW (1993) Osteopontin-hydroxyapatite interactions in vitro: inhibition of hydroxyapatite formation and growth in a gelatin-gel. Bone Miner 22:147–159PubMedCrossRef Boskey AL, Maresca M, Ullrich W, Doty SD, Butler WT, Prince CW (1993) Osteopontin-hydroxyapatite interactions in vitro: inhibition of hydroxyapatite formation and growth in a gelatin-gel. Bone Miner 22:147–159PubMedCrossRef
33.
Zurück zum Zitat Govindaraj A, Selvam R (2002) An oxalate-binding protein with crystal growth promoter activity from human kidney stone matrix. BJU Int 90:336–344PubMedCrossRef Govindaraj A, Selvam R (2002) An oxalate-binding protein with crystal growth promoter activity from human kidney stone matrix. BJU Int 90:336–344PubMedCrossRef
34.
Zurück zum Zitat Yamate T, Kohri K, Umekawa T et al (1996) The effect of osteopontin on the adhesion of calcium oxalate crystals to Madin–Darby canine kidney cells. Eur Urol 30:388–393PubMed Yamate T, Kohri K, Umekawa T et al (1996) The effect of osteopontin on the adhesion of calcium oxalate crystals to Madin–Darby canine kidney cells. Eur Urol 30:388–393PubMed
35.
Zurück zum Zitat Lieske JC, Toback FG, Deganello S (2001) Sialic acid-containing glycoproteins on renal cells determine nucleation of calcium oxalate dihydrate crystals. Kidney Int 60:1784–1791PubMedCrossRef Lieske JC, Toback FG, Deganello S (2001) Sialic acid-containing glycoproteins on renal cells determine nucleation of calcium oxalate dihydrate crystals. Kidney Int 60:1784–1791PubMedCrossRef
36.
Zurück zum Zitat Grases F, Isern B, Sanchis P, Perello J, Torres JJ, Costa-Bauza A (2007) Phytate acts as an inhibitor in formation of renal calculi. Front Biosci 12:2580–2587PubMedCrossRef Grases F, Isern B, Sanchis P, Perello J, Torres JJ, Costa-Bauza A (2007) Phytate acts as an inhibitor in formation of renal calculi. Front Biosci 12:2580–2587PubMedCrossRef
37.
Zurück zum Zitat Lomashvili KA, Cobbs S, Hennigar RA, Hardcastle KI, O’Neill WC (2004) Phosphate-induced vascular calcification: role of pyrophosphate and osteopontin. J Am Soc Nephrol 15:1392–1401PubMedCrossRef Lomashvili KA, Cobbs S, Hennigar RA, Hardcastle KI, O’Neill WC (2004) Phosphate-induced vascular calcification: role of pyrophosphate and osteopontin. J Am Soc Nephrol 15:1392–1401PubMedCrossRef
38.
Zurück zum Zitat Wilson JW, Werness PG, Smith LH (1985) Inhibitors of crystal growth of hydroxyapatite: a constant composition approach. J Urol 134:1255–1258PubMed Wilson JW, Werness PG, Smith LH (1985) Inhibitors of crystal growth of hydroxyapatite: a constant composition approach. J Urol 134:1255–1258PubMed
39.
Zurück zum Zitat Evan AP, Coe FL, Lingeman JE, Shao Y, Sommer AJ, Bledsoe SB, Anderson JC, Worcester EM (2007) Mechanism of formation of human calcium oxalate renal stones on Randall’s plaque. Anat Rec 290:1315–1323CrossRef Evan AP, Coe FL, Lingeman JE, Shao Y, Sommer AJ, Bledsoe SB, Anderson JC, Worcester EM (2007) Mechanism of formation of human calcium oxalate renal stones on Randall’s plaque. Anat Rec 290:1315–1323CrossRef
40.
Zurück zum Zitat Evan AP, Weinman EJ, Wu XR, Lingeman JE, Worcester EM, Coe FL (2010) Comparison of the pathology of interstitial plaque in human ICSF stone patients to NHERF-1 and THP-null mice. Urol Res 38:439–452PubMedCentralPubMedCrossRef Evan AP, Weinman EJ, Wu XR, Lingeman JE, Worcester EM, Coe FL (2010) Comparison of the pathology of interstitial plaque in human ICSF stone patients to NHERF-1 and THP-null mice. Urol Res 38:439–452PubMedCentralPubMedCrossRef
41.
Zurück zum Zitat Takeuchi A, Ohtsuki C, Miyazaki T, Kamitakahara M, Ogata S, Yamazaki M, Furutani Y, Kinoshita H, Tanihara M (2005) Heterogeneous nucleation of hydroxyapatite on protein: structural effect of silk sericin. J R Soc Interface 2:373–378PubMedCentralPubMedCrossRef Takeuchi A, Ohtsuki C, Miyazaki T, Kamitakahara M, Ogata S, Yamazaki M, Furutani Y, Kinoshita H, Tanihara M (2005) Heterogeneous nucleation of hydroxyapatite on protein: structural effect of silk sericin. J R Soc Interface 2:373–378PubMedCentralPubMedCrossRef
42.
Zurück zum Zitat Thamilselvan S, Hackett RL, Khan SR (1997) Lipid peroxidation in ethylene glycol induced hyperoxaluria and calcium oxalate nephrolithiasis. J Urol 157:1059–1063PubMedCrossRef Thamilselvan S, Hackett RL, Khan SR (1997) Lipid peroxidation in ethylene glycol induced hyperoxaluria and calcium oxalate nephrolithiasis. J Urol 157:1059–1063PubMedCrossRef
43.
Zurück zum Zitat Schwarz A (1993) Beethoven’s renal disease based on his autopsy: a case of papillary necrosis. Am J Kidney Dis 21:643–652PubMedCrossRef Schwarz A (1993) Beethoven’s renal disease based on his autopsy: a case of papillary necrosis. Am J Kidney Dis 21:643–652PubMedCrossRef
44.
Zurück zum Zitat Pieras E, Costa-Bauzá A, Ramis M, Grases F (2006) Papillary and nonpapillary calcium oxalate monohydrate renal calculi: comparative study of etiologic factors. Sci World J 6:2411–2419CrossRef Pieras E, Costa-Bauzá A, Ramis M, Grases F (2006) Papillary and nonpapillary calcium oxalate monohydrate renal calculi: comparative study of etiologic factors. Sci World J 6:2411–2419CrossRef
45.
Zurück zum Zitat Tarnawski A, Szabo IL, Husain SS, Soreghan B (2001) Regeneration of gastric mucosa during ulcer healing is triggered by growth factors and signal transduction pathways. J Physiol Paris 95:337–344PubMedCrossRef Tarnawski A, Szabo IL, Husain SS, Soreghan B (2001) Regeneration of gastric mucosa during ulcer healing is triggered by growth factors and signal transduction pathways. J Physiol Paris 95:337–344PubMedCrossRef
Metadaten
Titel
On the origin of calcium oxalate monohydrate papillary renal stones
verfasst von
Fèlix Grases
Antonia Costa-Bauzá
Carlo R. Bonarriba
Enrique C. Pieras
Rafael A. Fernández
Adrián Rodríguez
Publikationsdatum
01.01.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Urolithiasis / Ausgabe Sonderheft 1/2015
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-014-0697-5

Weitere Artikel der Sonderheft 1/2015

Urolithiasis 1/2015 Zur Ausgabe

Invited Review

Foreword

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.